Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined psychiatric treatment program with escitalopram for anxiety and depressive symptoms in oncology patients and their primary caregivers
2005-002655-41Phase 4Active
- Sponsor
- Hospital Universitario La Paz
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of escitalopram in adjustment disorder (AD), sponsored by Hospital Universitario La Paz. Primary endpoints: Efficacy assessment at 1 year, Maximum study duration and 3 more. Started Jun 2005; status: active.
02
Drugs
escitalopram
03
Conditions
adjustment disorder (AD)
Beyond the preview
Go deeper on 2005-002655-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002655-41.